These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3132091)

  • 1. Routes of quinolone permeation in Escherichia coli.
    Chapman JS; Georgopapadakou NH
    Antimicrob Agents Chemother; 1988 Apr; 32(4):438-42. PubMed ID: 3132091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorometric assay for fleroxacin uptake by bacterial cells.
    Chapman JS; Georgopapadakou NH
    Antimicrob Agents Chemother; 1989 Jan; 33(1):27-9. PubMed ID: 2540707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
    Pace J; Bertasso A; Georgopapadakou NH
    Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fleroxacin resistance in Escherichia coli.
    Chapman JS; Bertasso A; Georgopapadakou NH
    Antimicrob Agents Chemother; 1989 Feb; 33(2):239-41. PubMed ID: 2541657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli.
    Hancock RE; Farmer SW; Li ZS; Poole K
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1309-14. PubMed ID: 1656859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of divalent cations, quinolones and bacteria.
    Marshall AJ; Piddock LJ
    J Antimicrob Chemother; 1994 Oct; 34(4):465-83. PubMed ID: 7868402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Hirai K; Aoyama H; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Mar; 29(3):535-8. PubMed ID: 3521490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
    Maeda H; Fujii A; Nakata K; Arakawa S; Kamidono S
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1080-1. PubMed ID: 2847640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R; Andrews JM; Ashby JP; Matthews RS
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
    Digranes A; Benonisen E; Salveson A; Zahm F
    Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of the dual-action cephalosporin Ro 23-9424.
    Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High salt concentrations increase permeability through OmpC channels of Escherichia coli.
    Kojima S; Nikaido H
    J Biol Chem; 2014 Sep; 289(38):26464-26473. PubMed ID: 25086034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Cullmann W; Dechène M; Stieglitz M
    Immun Infekt; 1988 Aug; 16(4):152-8. PubMed ID: 3141267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1989; 35(6):423-30. PubMed ID: 2515040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of magnesium and sodium ions on the outer membrane permeability of cephalosporins in Escherichia coli.
    Yamaguchi A; Yanai M; Tomiyama N; Sawai T
    FEBS Lett; 1986 Nov; 208(1):43-7. PubMed ID: 3533634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of Ro 23-6240, a new fluorinated 4-quinolone.
    Stobberingh EE; Houben AW; van Boven CP
    Chemotherapy; 1987; 33(3):197-203. PubMed ID: 3109817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the expression of ompF and quinolone resistance in Escherichia coli.
    Kishii R; Takei M
    J Infect Chemother; 2009 Dec; 15(6):361-6. PubMed ID: 20012725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quinolones on nucleoid segregation in Escherichia coli.
    Georgopapadakou NH; Bertasso A
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2645-8. PubMed ID: 1810201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.
    Gasser TC; Graversen PH; Madsen PO
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1010-3. PubMed ID: 3116916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.